SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-04-000821
Filing Date
2004-03-11
Accepted
2004-03-11 08:14:19
Documents
3
Period of Report
2004-03-10
Items
Item 12: Results of Operations and Financial Condition
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w95120e8vk.htm 8-K 7438
3 EXHIBIT 99.1 w95120exv99w1.htm EX-99.1 37621
4 GRAPHIC w95120novavax.gif GRAPHIC 2893
  Complete submission text file 0000950133-04-000821.txt   49775
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 04661662
SIC: 2836 Biological Products, (No Diagnostic Substances)